Latticon
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- Undisclosed
Investors
- 5
About Latticon
, trading as Latticon, utilizes technologies such as antibody fusion proteins, bispecific antibodies, and complementary bispecific ADCs to develop innovative drugs to address unmet clinical needs. The company focuses on malignant tumors and autoimmune diseases, utilizing cutting-edge antibody technologies such as antibody fusion proteins, bispecific antibodies, and complementary bispecific ADCs to develop innovative drugs with enhanced safety, better clinical efficacy, and global intellectual property. The company generates revenue through drug manufacturing, medical research and experimental development, engineering and technology research and experimental development, technology transfer, and technology promotion.
Who invested in Latticon
5 investors across 3 rounds
See all investors in Latticon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Latticon
Who invested in Latticon?
Latticon has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Latticon raised?
Latticon has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Latticon last raise money?
Latticon's most recent round on record is a Series A, in Sep 2026.
What does Latticon do?
, trading as Latticon, utilizes technologies such as antibody fusion proteins, bispecific antibodies, and complementary bispecific ADCs to develop innovative drugs to address unmet clinical needs.
Where is Latticon headquartered?
Latticon is headquartered in Suzhou, China.
Which VCs invest in companies like Latticon?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Latticon's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Latticon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.